Concepedia
Statistics
Publications
9
Citations
878
H-Index
Active since
2004
Affiliations
Exelixis (United States)(Current)
Bristol-Myers Squibb (Germany)
Bristol-Myers Squibb (United States)
Bristol-Myers Squibb (Sweden)
Rutgers, The State University of New Jersey
Richard Martin is an author at Exelixis (United States) specializing in pharmacology, molecular pharmacology, and drug discovery.
Publications per year
2004–2016
Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand
Patricia J. Willy, Ian Murray, Jing Qian et al. · Proceedings of the National Academy of Sciences · 2004 · 193 citations · Full text
Life Sciences, Molecular Biology, Pharmacology +17
Identification of a Selective Inverse Agonist for the Orphan Nuclear Receptor Estrogen-Related Receptor α
Brett B. Busch, William C. Stevens, Richard Martin et al. · Journal of Medicinal Chemistry · 2004 · 170 citations · Full text
Life Sciences, Endocrinology, Pharmacology +17
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils
Todd G. Kirchgessner, Paul G. Sleph, Jacek Ostrowski et al. · Cell Metabolism · 2016 · 164 citations · Full text
Life Sciences, Molecular Medicine, Pharmacology +17
Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)
Brenton Flatt, Richard Martin, Tielin Wang et al. · Journal of Medicinal Chemistry · 2009 · 161 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Transdermal and transbuccal drug delivery systems: Enhancement using iontophoretic and chemical approaches
Longsheng Hu, Sérgio M.C. Silva, Bassam B. Damaj et al. · International Journal of Pharmaceutics · 2011 · 45 citations
Pharmacy, Pharmaceutics, Pharmacology +14
1–5 of 9